NEW YORK (GenomeWeb News) – Zygem and Phthisis Diagnostics announced Thursday that they will collaborate on developing products for the detection of infectious pathogens in complex samples, such as stool, blood, and water.

The partnership will combine Zygem's enzymatic nucleic acid extraction technology with Phthisis' molecular diagnostic test expertise to develop products that can rapidly obtain high-quality DNA from infectious pathogens. The firms will initially focus on extracting pathogen DNA from stool.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.